From Our Partners
Wednesday, June 29, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home News Scan

Biodefense News Headlines of the Week – August 24, 2014

by Global Biodefense Staff
August 24, 2014
Global Biodefense News - MRSA

Global Biodefense News - MRSAGlobal fear of Ebola outbreak stokes a frenzy of new R&D | Air Force Secretary doubles down on nuclear mission | Analysis of chemicals relevant to the Chemical Weapons Convention | Marburg drug shows promise | Harnessing the power of convalescents for severe viral infections | Ebola puts focus on drugs made in tobacco plants | Why are so many women dying from Ebola? | Assessing FDA’s final guidance on companion diagnostics | 4th MEB trains for disaster on the homefront | Chikungunya vaccine clears Phase 1 | Treatment in U.S. rare chance to study Ebola | Seals infected early Americans with tuberculosis | Ebola crisis: Ivory Coast closes land borders | Plants and their growing role in the pharmaceutical industry | Confronting biological plagues like Ebola, smallpox, and anthrax | WHO: Ebola outbreak underestimated | Containing the international spread of Ebola | Large trial finds high-dose flu shot beneficial for seniors| Those who serve Ebola victims soldier on

See what we’re reading this week at Global Biodefense on plant-based vaccines, chemicals relevant to the Chemical Weapons Convention, Chikungunya vaccine and more…

Global fear of Ebola outbreak stokes a frenzy of new R&D (Fierce Biotech)

Air Force Secretary doubles down on nuclear mission (Defense One)

Marburg drug shows promise (The Scientist)

Analysis of chemicals relevant to the Chemical Weapons Convention (Springer Link)

Harnessing the power of convalescents for severe viral infections (UPMC CBN)

Ebola puts focus on drugs made in tobacco plants (Seattle Times)

Why are so many women dying from Ebola? (Foreign Policy)

Assessing FDA’s final guidance on companion diagnostics (MDT)

4th MEB trains for disaster on the homefront (DVIDS)

Chikungunya vaccine clears Phase 1 (The Scientist)

Treatment in U.S. rare chance to study Ebola (NY Times)

Seals infected early Americans with tuberculosis (Science)

Ebola crisis: Ivory Coast closes land borders (BBC News)

Plants and their growing role in the pharmaceutical industry (Pandora Report)

Confronting biological plagues like Ebola, smallpox, and anthrax (GEN)

WHO: Ebola outbreak underestimated (The Scientist)

Containing the international spread of Ebola (The Conversation)

Large trial finds high-dose flu shot beneficial for seniors (CIDRAP)

Those who serve Ebola victims soldier on (NY Times)

From Our Partners
Tags: ChikungunyaEbolaMarburgVaccines

Related Posts

Biodefense Headlines – 16 June 2022
News Scan

Biodefense Headlines – 16 June 2022

June 16, 2022
Biodefense Headlines – 29 May 2022
News Scan

Biodefense Headlines – 29 May 2022

May 29, 2022
Biodefense Headlines – 4 May 2022
News Scan

Biodefense Headlines – 4 May 2022

May 4, 2022
Biodefense Headlines – 5 April 2022
News Scan

Biodefense Headlines – 5 April 2022

April 5, 2022
Load More

Latest News

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

June 22, 2022
Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

June 22, 2022
UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Influenza Research

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC